Business Context and Reporting Period
This Form 8-K reports on events occurring at the 2025 Annual Meeting of Stockholders for MaxCyte, Inc. held on June 18, 2025. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol MXCT. The filing primarily addresses corporate governance actions, including the election of directors and the approval of an equity plan amendment.
Key Financial Metrics
This filing is a current report regarding corporate events and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Corporate Actions
- Equity Plan Amendment: Stockholders approved an amendment to the 2022 Equity Incentive Plan, increasing the maximum number of authorized shares by 2,950,000.
- Director Elections: Three Class I directors were elected: Maher Masoud, Yasir Al-Wakeel, and Rekha Hemrajani.
- Delisting from AIM: Stockholders approved the cancellation of the admission of the Company's common stock to trading on the AIM market of the London Stock Exchange.
- Auditor Ratification: The selection of CohnReznick LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Voting Results Summary
| Proposal | For | Against | Abstain |
|---|---|---|---|
| Election of Class I Directors (Maher Masoud) | 69,794,241 | 11,013,848 | N/A |
| Election of Class I Directors (Yasir Al-Wakeel) | 58,901,844 | 21,906,245 | N/A |
| Election of Class I Directors (Rekha Hemrajani) | 59,111,391 | 21,696,698 | N/A |
| Approval of Plan Amendment | 74,124,667 | 6,481,735 | 201,687 |
| Delisting from London AIM | 82,894,212 | 4,288,690 | 238,268 |
| Ratification of Auditor | 87,039,354 | 58,701 | 323,115 |
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific risk factors. It notes that the proposal to adjourn the meeting was deemed moot as all other proposals passed.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the Amended and Restated 2022 Equity Incentive Plan to assess potential dilution from the 2,950,000 share increase.
- Confirm the effective date of the delisting from the London Stock Exchange AIM market.
- Review the definitive proxy statement filed on April 28, 2025, for detailed terms of the equity plan amendment.
- Note that the company is classified as an emerging growth company.